Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

8.24
Delayed Data
As of Jul 02
 +0.08 / +0.98%
Today’s Change
5.65
Today|||52-Week Range
9.24
+9.87%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close8.16
Today’s open8.20
Day’s range8.18 - 8.24
Volume11,677
Average volume (3 months)24,073
Market cap$78.7M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-26.14%
Earnings growth (this year)-14.41%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+16,502.46%
P/E ratioNM
Price/Sales41.26
Price/Book9.36

Competitors

 Today’s
change
Today’s
% change
ITEKInotek Pharmaceutica...-0.06-1.23%
MSTXMast Therapeutics In...-0.01-2.04%
CRBPCorbus Pharmaceutica...-0.02-0.65%
ORMPOramed Pharmaceutica...+1.12+19.21%
Data as of 4:01pm ET, 07/02/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$1.7M
Annual profit (last year)-$10.1M
Net profit margin-609.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers